Fibroma epidemiology and demographics: Difference between revisions
No edit summary |
Simrat Sarai (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Non-ossifying Fibroma=== | |||
===Prevalence=== | ===Prevalence=== | ||
The prevalence of fibroma is estimated to be [number] cases annually. | |||
===Incidence=== | ===Incidence=== | ||
===Age=== | |||
=== | Non-ossifying fibromas are the most common fibrous bony lesions in children and adolescents, with a peak incidence at 10-15 years old. Non-ossifying fibromas are not seen beyond the age of 30 years, as they spontaneously heal. | ||
===Gender=== | ===Gender=== | ||
Males are more commonly affected with non-ossifying fibromas than females. The male to female ratio is approximately 2 to 1. | |||
===Race=== | ===Race=== | ||
Revision as of 21:07, 29 February 2016
|
Fibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibroma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Fibroma epidemiology and demographics |
|
Risk calculators and risk factors for Fibroma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Epidemiology and Demographics
Non-ossifying Fibroma
Prevalence
The prevalence of fibroma is estimated to be [number] cases annually.
Incidence
Age
Non-ossifying fibromas are the most common fibrous bony lesions in children and adolescents, with a peak incidence at 10-15 years old. Non-ossifying fibromas are not seen beyond the age of 30 years, as they spontaneously heal.
Gender
Males are more commonly affected with non-ossifying fibromas than females. The male to female ratio is approximately 2 to 1.